Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00564681 · ClinicalTrials.gov registry record · Phase 2
Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia
A Phase 2 study, sponsored by Allergan.
- Completed
- Registry status
- Phase 2
- Development phase
- 242
- Enrollment target
NCT00564681 is a Phase 2 study that has completed, run by Allergan. The registered enrollment target is 242 participants.
The verdict
NCT00564681, a Phase 2 study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 242 participants
- Enrollment target
Study Summary
Study is to investigate the use of the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) scale in a cervical dystonia population treated with botulinum toxin type A, and placebo.
Interventions
- DRUG Normal Saline
- BIOLOGICAL botulinum toxin type A
- BIOLOGICAL botulinum toxin type A Formulation 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2007-12 |
| Est. Completion | 2009-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00564681
The ClinicalTrials.gov registry entry for NCT00564681 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 242 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Normal Saline is the first listed.
NCT00564681 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00564681 about?
NCT00564681 is a clinical study titled "Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia". Study is to investigate the use of the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) scale in a cervical dystonia population treated with botulinum toxin type A, and placebo.
What is the current status of trial NCT00564681?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 242 participants. The study started on 2007-12. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00564681?
The interventions under investigation include: Normal Saline (DRUG), botulinum toxin type A (BIOLOGICAL), botulinum toxin type A Formulation 2 (BIOLOGICAL).
Who is sponsoring clinical trial NCT00564681?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.